Literature DB >> 24133967

[Epigenetic mechanisms of Alzheimer's disease and related drug research].

Hui-Cui Gong1, Yun-Liang Wang, Hong-Wei Wang.   

Abstract

Alzheimer's disease (AD) is a neurodegenerative disorder characteristic of neurons reducing, senile plaques, neurofibrillary tangles and so on, and the most common cause of dementia among the elderly. Many efforts have been made to understand the epigenetic mechanisms involved in the development of AD, such as gene methylation and histone acetylation, although the exact mechanisms are not yet entirely clear. Here, we provide a review of the epigenetic mechanisms and related research in AD, which may provide a new direction for the research as well as the development of the epigenetic drugs.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24133967

Source DB:  PubMed          Journal:  Yao Xue Xue Bao        ISSN: 0513-4870


  1 in total

1.  MGCD0103, a selective histone deacetylase inhibitor, coameliorates oligomeric Aβ25-35 -induced anxiety and cognitive deficits in a mouse model.

Authors:  Hei-Jen Huang; Hsin-Yu Huang; Hsiu Mei Hsieh-Li
Journal:  CNS Neurosci Ther       Date:  2018-07-05       Impact factor: 5.243

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.